PRIA Quarterly Review - Q2 Highlights
July 17, 2025
In this issue of PRIA Pages, read about all that the PRIA team was up to in the MedTech industry in Q2 2025! LSI Asia, LSX, & Medtech Strategist's Innovation Summit were major global conferences that PRIA was thrilled to participate in as a sponsor. The team also engaged in the ecosystem locally, mentored early-stage innovators, and stayed current with industry policy. We hosted a webinar on the changes coming to Medicare Advantage and how they impact MedTech. We also wrote articles, judged pitch events, and not least of all, moved to a beautiful new location!
Click to View the PDF
Click the Icon below to share this with your network
You Got Your 510(k). Now What?
Right Sizing Your Quality System
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's Second Quarter in Review
Continuing and Strengthening our Relationship with a Vital Industry Event
A leader in Reimbursement & Market Access Services, PRIA has followed developments on WISeR. Here is our summary of the new CMS Provider & Supplier Operational Guide
